Phosphatidylinositol 3-OH kinase activity is not required for activation of mitogen-activated protein kinase by cytokines

被引:54
|
作者
Scheid, MP [1 ]
Duronio, V [1 ]
机构
[1] UNIV BRITISH COLUMBIA,DEPT MED,JACK BELL RES CTR,VANCOUVER,BC V6H 3Z6,CANADA
关键词
D O I
10.1074/jbc.271.30.18134
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hemopoietic cells respond to cytokines by initiating tyrosine phosphorylation of receptors and receptor-associated proteins, leading to the activation of numerous cytosolic and membrane associated enzymes, including phosphatidylinositol 3-OH kinase (PI 3-kinase). Recent reports have suggested that PIS-kinase may serve as an upstream activator of mitogen-activated protein (MAP) kinase. After stimulation with interleukin-3 and granulocyte-macrophage colony stimulating factor, we show here that inhibition of MAP kinase activity by two inhibitors of PI 3-kinase, wortmannin and LY-294002, does not correlate with their ability to inhibit PI 3-kinase or p70 S6 kinase phosphorylation. Complete inhibition of phosphatidylinositol 3,4,5-trisphosphate production occurred at approximately 100 nM WM or 25 mu M LY-294002, but at these concentrations, WM significantly inhibited MAP kinase activation, while LY-294002 had virtually no effect on MAP kinase activity. Furthermore, WM does not inhibit phorbol ester-mediated MAP kinase activation, but LY-294002 does. Together these results suggest WM and LY-294002 are differentially inhibiting enzymes other than PI 3-kinase that function upstream of MAP kinase.
引用
收藏
页码:18134 / 18139
页数:6
相关论文
共 50 条
  • [21] Inhibition of human cardiac fibroblast mitogenesis by blockade of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
    Hafizi, S
    Chester, AH
    Yacoub, MH
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (07) : 511 - 513
  • [22] Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase
    Whalen, AM
    Galasinski, SC
    Shapiro, PS
    Nahreini, TS
    Ahn, NG
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) : 1947 - 1958
  • [23] Mitogen-Activated Protein Kinase Kinase 3 Is Required for Regulation during Dark-Light Transition
    Lee, Horim
    [J]. MOLECULES AND CELLS, 2015, 38 (07) : 651 - 656
  • [24] Changes in the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling associated with the induction of apoptosis
    Marushige, K
    Marushige, Y
    [J]. ANTICANCER RESEARCH, 1999, 19 (5B) : 3865 - 3871
  • [25] Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase
    Amin, MA
    Volpert, OV
    Woods, JM
    Kumar, P
    Harlow, LA
    Koch, AE
    [J]. CIRCULATION RESEARCH, 2003, 93 (04) : 321 - 329
  • [26] MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IS REQUIRED FOR THE MOS-INDUCED METAPHASE
    KOSAKO, H
    GOTOH, Y
    NISHIDA, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (45) : 28354 - 28358
  • [27] Simultaneous inhibition of the mitogen-activated protein kinase kinase and phosphatidylinositol 3'-kinase pathways enhances sensitivity to paclitaxel in ovarian carcinoma
    Kawaguchi, Wakae
    Itamochi, Hiroaki
    Kigawa, Junzo
    Kanamori, Yasunobu
    Oishi, Tetsuro
    Shimada, Muneaki
    Sato, Sinya
    Shimogai, Ruri
    Sato, Seiya
    Terakawa, Naoki
    [J]. CANCER SCIENCE, 2007, 98 (12) : 2002 - 2008
  • [28] Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function
    Coffer, PJ
    Geijsen, N
    M'Rabet, L
    Schweizer, RC
    Maikoe, T
    Raaijmakers, JAM
    Lammers, JWJ
    Koenderman, L
    [J]. BIOCHEMICAL JOURNAL, 1998, 329 : 121 - 130
  • [29] Novel mitogen-activated protein kinase kinase inhibitors
    Chapman, Mark S.
    Miner, Jeffrey N.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (02) : 209 - 220
  • [30] Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line
    Ogawa, M
    Nishiura, T
    Oritani, K
    Yoshida, H
    Yoshimura, M
    Okajima, Y
    Ishikawa, J
    Hashimoto, K
    Matsumura, I
    Tomiyama, Y
    Matsuzawa, Y
    [J]. CANCER RESEARCH, 2000, 60 (15) : 4262 - 4269